| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 1 | 1998 | Serum alpha-fetoprotein surge after the iniation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance | SYLVESTER, Richard; de Wit, R.; Collette, L.; de Mulder, P.H.M.; Sleijfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G. | Journal Contribution | |
| 2 | 1998 | Four cycles of BEP vs four cycles of VIR in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group | de Wit, R.; Stoter, G.; Sleijfer, D.T.H.; Neijt, J.P.; ten Bokkel Huinink, W.W.; de Prijck, L.; Collette, L.; SYLVESTER, Richard | Journal Contribution | |
| 3 | 1997 | Importance of bleomycin in combination chemotherapy for good prognosis testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group | de Wit, R.; Stoter, G.; Kaye, S.B.; Steijffer, D.Th.; Jones, W.G.; ten Bokkel Huinink, W.W.; Rea, L.A.; Collette, L.; SYLVESTER, Richard | Journal Contribution | |
| 4 | 1997 | Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminatomous testicular cancer | de Wit, R.; SYLVESTER, Richard; Tsitsa, C.; de Mulder, P.H.M.; Sleyfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; van Oosterom, A.T.; Boven, E.; Stoter, G. | Journal Contribution | |
| 5 | 1991 | Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery | Jansen, R.L.H.; SYLVESTER, Richard; Sleyfer, D.T.; ten Bokkel Huinink, W.W.; Kaye, S.B.; Jones, W.G.; Keizer, J.; van Oosterom, A.T.; Meyer, S.; Vendrik, C.P.J.; de Pauw, M.; Stoter, G. | Journal Contribution | |